Stock listing
A0B9A5 Stock Price, News, Filings & Events — Angiodynamics, Inc.
Selected listing: A0B9A5 · LSX · EUR · DE
This page tracks Angiodynamics, Inc.'s A0B9A5:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0B9A5:LSX. A0B9A5:LSX is the stock-level entry point for investors researching Angiodynamics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A0B9A5:LSX
- Asset type
- Stock
- Market cap
- $640.2M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LSX
- Currency
- EUR
Angiodynamics, Inc. A0B9A5:LSX stock context
This page tracks Angiodynamics, Inc.'s A0B9A5:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0B9A5:LSX. A0B9A5:LSX is the stock-level entry point for investors researching Angiodynamics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Angiodynamics, Inc.
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026
September 28, 2026
AngioDynamics : Press space to expand and collapse this section AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
July 14, 2026
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
July 14, 2026
AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026
June 30, 2026
AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)
June 17, 2026
Angiodynamics, Inc. earnings calls
AngioDynamics, Inc. (ANGO) Q4 2026 Earnings Call
July 14, 2026 · Replay with transcript and chapters
AngioDynamics, Inc. (ANGO) Q3 2026 Earnings Call
April 2, 2026 · Replay with transcript and chapters
AngioDynamics, Inc. (ANGO) Q2 2026 Earnings Call
January 6, 2026 · Replay with transcript and chapters
AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call
October 2, 2025 · Replay with transcript and chapters
AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Call
July 15, 2025 · Replay with transcript and chapters
AngioDynamics, Inc. (ANGO) Q3 2025 Earnings Call
April 2, 2025 · Replay with transcript and chapters
Research Angiodynamics, Inc.
Angiodynamics, Inc. investor report
Review AI stock analysis and investor report context for A0B9A5:LSX.
Angiodynamics, Inc. company profile
View the public company page for Angiodynamics, Inc. on 6ix.
Angiodynamics, Inc. news
Read company news and market updates connected to Angiodynamics, Inc..
Angiodynamics, Inc. investor events
Find investor webinars, events, and replay context for Angiodynamics, Inc..
Alternate listings
ANGO:NASDAQ
US · USD
Alternate listing for Angiodynamics, Inc.; the primary context on this page is A0B9A5:LSX.
UG2:GETTEX
DE · EUR
Alternate listing for Angiodynamics, Inc.; the primary context on this page is A0B9A5:LSX.
ANGO:BOATS
US · USD
Alternate listing for Angiodynamics, Inc.; the primary context on this page is A0B9A5:LSX.
A0B9A5:LS
DE · EUR
Alternate listing for Angiodynamics, Inc.; the primary context on this page is A0B9A5:LSX.
UG2:TRADEGATE
DE · EUR
Alternate listing for Angiodynamics, Inc.; the primary context on this page is A0B9A5:LSX.
UG2:DUS
DE · EUR
Alternate listing for Angiodynamics, Inc.; the primary context on this page is A0B9A5:LSX.
UG2:FWB
DE · EUR
Alternate listing for Angiodynamics, Inc.; the primary context on this page is A0B9A5:LSX.
UG2:MUN
DE · EUR
Alternate listing for Angiodynamics, Inc.; the primary context on this page is A0B9A5:LSX.
UG2:SWB
DE · EUR
Alternate listing for Angiodynamics, Inc.; the primary context on this page is A0B9A5:LSX.